New horizons for treatment of ANCA-associated vasculitides
- PMID: 21729933
- DOI: 10.1093/rheumatology/ker187
New horizons for treatment of ANCA-associated vasculitides
Comment on
-
Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.Rheumatology (Oxford). 2012 Apr;51(4):634-43. doi: 10.1093/rheumatology/ker150. Epub 2011 May 25. Rheumatology (Oxford). 2012. PMID: 21613248
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
